Carotenóides na prevenção e no tratamento da síndrome metabólica / Carotenoids in the prevention and treatment of metabolic syndrome
DOI:
https://doi.org/10.34119/bjhrv3n5-332Keywords:
Síndrome metabólica, Compostos fitoquímicos, Carotenóides.Abstract
A síndrome metabólica é uma combinação de distúrbios que aumentam o risco de desenvolver doenças cardiovasculares e diabetes, e está relacionada inversamente com o conteúdo de carotenóides, especialmente ?-caroteno e ?-criptoxantina e com o número de componentes da síndrome metabólica, ou seja, uma dieta enriquecida com carotenóides está associada a uma menor prevalência desta doença. Portanto, o presente estudo objetivou abordar o papel dos carotenóides no tratamento da síndrome metabólica. Os carotenóides possuem uma ampla gama de bioatividades contra comorbidades associadas à síndrome metabólica e regulação de vários mecanismos moleculares que medeiam esta patologia, como por exemplo, redução da pressão arterial e da resistência à insulina e manutenção da homeostase lipídica, no qual estes compostos bioativos podem ser administrados como uma suplementação segura e eficiente no caso de componentes da síndrome metabólica, embora ainda não tenha a determinação da dosagem ideal e do período de suplementação, tornando-se necessário mais investigações.
References
ALGANDABY, M.M. Crocin attenuates metabolic syndrome?induced osteoporosis in rats. Journal of Food Biochemistry, v. 43, n. 7, p. 1-8, 2019.
ALGANDABY, M.M. Crocin prevents metabolic syndrome in rats via enhancing PPAR-gamma and AMPK. Saudi Journal of Biological Sciences, v. 27, n. 1, p. 1310-1316, 2020.
BARONA, J. et al. A Mediterranean-style low-glycemic-load diet increases plasma carotenoids and decreases LDL oxidation in women with metabolic syndrome?. The Journal of Nutritional Biochemistry, v. 23, n. 6, p. 609-615, 2012.
BEYDOUN, M.A. et al. Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent National Surveys. The Journal of Nutrition, v. 141, n. 5, p. 903–913, 2011.
BOH, T. et al. Mind the gap—deficits in our knowledge of aspects impacting the bioavailability of phytochemicals and their metabolites—a position paper focusing on carotenoids and polyphenols. Molecular Nutrition Food Research, v. 59, n. 7, p. 1307-1323, 2015.
BUKHARI, S.I. et al. A comprehensive review of the pharmacological potential of Crocus sativus and its bioactive apocarotenoids. Biomedicine & Pharmacotherapy, v. 98, n. 1, p. 733-745, 2018.
CALIXTO, S.C.S. et al. Prevalência da síndrome metabólica em idosos. Revista Saúde em Foco, v. 3, n. 2, p. 119-135, 2016.
CARBONELL-CAPELLA, J.M. et al. Analytical methods for determining bioavailability and bioaccessibility of bioactive compounds from fruits and vegetables: A review. Comprehensive Reviews in Food Science and Food Safety, v. 13, n. 2, p. 155-171, 2014.
CERVANTES-PAZ, B. et al. Effects of pectin on lipid digestion and possible implications for carotenoid bioavailability during pre-absorptive stages: A review. Food Research International, v. 99, n. 2, p. 917-927, 2017.
CICERO, A.F.G.; COLLETI, A. Role of phytochemicals in the management of metabolic syndrome. Phytomedicine, v. 23, n. 11, p. 1134-1144, 2016.
COSTA, F.F. et al. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, v. 14, n. 1, p. 809-814, 2020.
CHENG, H.M. et al. Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis. Atherosclerosis, v. 257, n. 1, p. 100-108, 2017.
DESMARCHELIER, C.; BOREL, P. Overview of carotenoid bioavailability determinants: From dietary factors to host genetic variations. Trends in Food Science & Technology, v. 69, n. 5, p. 270-280, 2017.
EL-FAWAL, R. et al. Diosmin and crocin alleviate nephropathy in metabolic syndrome rat model: Effect on oxidative stress and low grade inflammation. Biomedicine & Pharmacotherapy, v. 102, n. 3, p. 930-937, 2018.
FERREIRA-SANTOS, P. et al. Lycopene-supplemented diet ameliorates metabolic syndrome induced by fructose in rats. Journal of Functional Foods, v. 73, n. 8, p. 1-9, 2020.
FRANCINI-PESENTI, F.; SPINELLA, P.; CALÒ, L.A. Potential role of phytochemicals in metabolic syndrome prevention and therapy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, v. 12, n. 1, p. 1987-2002, 2019.
HAN, G.M. et al. Higher levels of serum lycopene are associated with reduced mortality in individuals with metabolic syndrome?,??. Nutrition Research, v. 36, n. 5, p. 402-407, 2016.
HOLT, E.W.; WEI, E.K.; BENNETT, N.; ZHANG, L.M. Low skin carotenoid concentration measured by resonance Raman spectroscopy is associated with metabolic syndrome in adults. Nutrition Research, v. 34, n. 10, p. 821-826, 2014.
JAVANDOOST, A. et al. Effect of crocin, a carotenoid from saffron, on plasma cholesteryl ester transfer protein and lipid profile in subjects with metabolic syndrome: A double blind randomized clinical trial. Arya Atherosclerosis, v. 13, n. 5, p. 245-252, 2017.
JU, S.Y.; LEE, J.Y.; KIM, D.H. Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: A meta-analysis of prospective cohort studies. Medicine, v. 96, n. 45, p.1-9, 2017.
LARSEN, J.R.; DIMA, L.; CU, C.; MANU, P. The pharmacological management of metabolic syndrome. Expert Review of Clinical Pharmacology, v. 11, n. 4, p. 397-410, 2018.
LINTING, J.V.; MOON, J.; LEE, J.; RAMKUMAR, S. Carotenoid metabolism at the intestinal barrier. Molecular and Cell Biology of Lipids, v. 1865, n. 11, p. 1-21, 2020.
NIKBAKHT-JAM, I. et al. Effect of crocin extracted from saffron on pro-oxidant–anti-oxidant balance in subjects with metabolic syndrome: A randomized, placebo-controlled clinical trial. European Journal of Integrative Medicine, v. 8, n. 1, p. 307-312, 2016.
OBEIDAT, A.A.; AHMAD, M.N.; HADDAD, F.H.; AZZEH, F.S. Alarming high prevalence of metabolic syndrome among Jordanian adults. Pakistan Journal of Medical Sciences, v. 31, n. 6, p. 1377-1382, 2015.
PARK, K. et al. Oxidative stress and insulin resistance. Diabetes Care, v. 32, n. 1, p. 1302–1307, 2009.
PALMIERI, V.O. et al. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. The Journal of Nutrition, v. 136, n. 1, p. 3022–3026, 2006.
RODRIGUEZ-CONCEPCION, M. et al. A global perspective on carotenoids: Metabolism, biotechnology, and benefits for nutrition and health. Progress in Lipid Research, v. 70, n. 4, p. 62-93, 2018.
SAINI, R.K.; NILE, S.H.; PARK, S.W. Carotenoids from fruits and vegetables: Chemistry, analysis, occurrence, bioavailability and biological activities. Food Research International, v. 76, n. 1, p. 735-750, 2015.
SAINI, R.K.; SIVANESAN, I.; KEUM, Y.S. Emerging roles of carotenoids in the survival and adaptations of microbes. Indian Journal of Microbiology, v. 59, n. 1, p.125–127, 2019.
SHAFEI, M.N. et al. Crocin prevents acute angiotensin II-induced hypertension in anesthetized rats. Avicenna Journal of Phytomedicine, v. 7, n. 4, p. 345-352, 2017.
SHIRALI, S. et al. Effect of crocin on the insulin resistance and lipid profile of streptozotocin?induced diabetic rats. Phytotherapy Research, v. 27, n. 7, p. 1042-1047, 2012.
SRIKANTHAN, K.; FEYH, A.; VISWESHWAR, H.; SHAPIRO, J.I.; SODHI, K. Systematic review of metabolic syndrome biomarkers: A panel for early detection, management, and risk stratification in the west virginian population. International Journal of Medical Sciences, v. 13, n. 1, p. 25-38, 2016.
THOMAS, S.E.; HARRISON, E.H. Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins. Journal of Lipid Research, v. 57, n. 1, p. 1865-1878, 2016.
